Cart
sales@molnova.com
CLK inhibitor T3
CAS No. 2109805-56-1
CLK inhibitor T3 ( T3 )
Catalog No. M13352 CAS No. 2109805-56-1
CLK inhibitor T3 (T3) is a highly potent, selective, and cell-based stable CDC-like kinase (CLK) inhibitor with 0.67, 15 and 110nM for CLK1,2 and 3, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 68 | Get Quote |
|
| 5MG | 113 | Get Quote |
|
| 10MG | 196 | Get Quote |
|
| 25MG | 417 | Get Quote |
|
| 50MG | 614 | Get Quote |
|
| 100MG | 872 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCLK inhibitor T3
-
NoteResearch use only, not for human use.
-
Brief DescriptionCLK inhibitor T3 (T3) is a highly potent, selective, and cell-based stable CDC-like kinase (CLK) inhibitor with 0.67, 15 and 110nM for CLK1,2 and 3, respectively.
-
DescriptionCLK inhibitor T3 (T3) is a highly potent, selective, and cell-based stable CDC-like kinase (CLK) inhibitor with 0.67, 15 and 110nM for CLK1,2 and 3, respectively; displays 200-300-fold selectivity over other dual specificity kinases such as DYRK1A and DYRK1B; induces dose-dependent reduction in exon recognition and exhibits an overlapping, but greater effect on transcriptome splicing compared to KH-CB19.
-
SynonymsT3
-
PathwayCell Cycle/DNA Damage
-
TargetCLK
-
RecptorCLK
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number2109805-56-1
-
Formula Weight482.59
-
Molecular FormulaC28H30N6O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC1=CN2C=C(C3=CC=NC=C3)C=CC2=N1)C4=CC=C(C(C)(C)C(N5CCN(C)CC5)=O)C=C4
-
Chemical Name4-(2-methyl-1-(4-methylpiperazin-1-yl)-1-oxopropan-2-yl)-N-(6-(pyridin-4-yl)imidazo[1,2-a]pyridin-2-yl)benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Funnell T, et al. Nat Commun. 2017 Feb 23;8(1):7.
molnova catalog
related products
-
K00546
K00546 is a potent inhibitor of the CDC2-like kinase CLK1 and CLK3 with IC50 of 8.9 and 29.2 nM, respectively.
-
SRI-29329
A potent, specific CDC-like kinase (CLK) inhibitor with IC50 of 78, 16 and 86 nM for CLK1, 2 and4, respectively; shows no significant activity for CLK3, CDK1, CDK4 and CDK6 (IC50>1,000 nM).
-
CLK inhibitor 2
A potent, selective inhibitor of cdc2-like kinase CLK1 and CLK2 with IC50 of 1.1 and 2.4 nM, respectively; moderately inhibits PI3Kα, and >100-fold selectivity over SRPK1/2/3.
